Top 5 Wellness Startup Investors in Taiwan in July 2025
A list of 5 angel investors and VC (Venture Capital) funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.Top 5 Wellness Startup Investors in Taiwan in July 2025
Investor | Wellness Taiwan investments |
---|---|
Suzhou Industrial Park Nankai Venture Capital | 1 |
Panacea Venture | 1 |
Yan Jin | 1 |
Zero2IPO Ventures | 1 |
Sino Biopharmaceutical | 1 |
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more
Investment focus
- Wellness, Health Care, Consumer Research
- Series A
- Taiwan
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Seed
- China, United States, Taiwan
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Chime Biologics — Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stagebiopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.
- Eos BioInnovation — Discover Eos Bioinnovation's commitment to advancing sustainable biotechnology through innovative research and development. Explore our mission and services.
Yan Jin has 15-year venture capital, investment banking, and corporate management experience covers more than 20 investment projects, involving consumer electronics, new materials, the Internet, and innovative services industries. Ms. Jin also serves as a leader of China’s Democratic National Construction Party, a political party separate from theCommunist Party of China. She is currently a legislative member of the Shenzhen Municipal Government. Ms. Jin is also a cofounder of Shenzhen Capital Group.
Show more
Investment focus
- Fitness, mHealth, Wellness
- Series A
- Taiwan
Portfolio highlights
- iFit — iFit (爱瘦身) is a website and mobile community that focuses on health and slimming services.iFit currently emphasizes on content, communities, and electronic commerce services. It plans on expanding its services into wearable equipment, application software, hardware services, and more. In March 2013, iFit gathered pictures and articles andpublished a book named Get Food not Fat, which was on the best-selling list once released. At the same time, IFit entered the group buying market.iFit was founded by Chen Yunru in June 2012. She started her business through a fan club by sharing her own experiences of losing weight. In less than a year her fan base reached more than 400,000. The official iFit website was set up in December 2012.
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more
Investment focus
- E-Commerce, Internet, Education
- Series A, Series B, Angel
- China, India, Taiwan
Portfolio highlights
- AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Series D, Series B, Series E
- China, United States, Israel
Portfolio highlights
- Medlinker — Medical Alliance is a post of physician social service platform. Users are certified doctors working in the Medical Alliance, they can share knowledge, experience and insights with the other industry elite, to continue to provide high quality content for each other. Application provides a medical quiz, map that case, the anonymous social circlesand doctors and other functions, is committed to helping physicians groups, more convenient access to high-quality information from the industry
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Generon (Shanghai) Corporation — Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Theirmission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Music
Art
Photography
Wellness
Franchise
Mobile
Clean Energy
Local
Digital Media
Legal
Android
eSports
Education
Enterprise Software
Sports
B2B
Manufacturing
Email
Medical
Financial Services
Social Network
Social Media
Internet
Construction
Big Data
Hospitality
Platforms
Biotechnology
Payments
Cannabis
Mobile Advertising
Travel
Fitness
Finance
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Organic Food
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
Food and Beverage
Web3
LGBT
Infrastructure
Retail
Beauty
Publishing
Video Games
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
SaaS
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Agriculture (agtech)
Machine Learning
Media (entertainment)
Blockchain
Facebook
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Panama
Poland
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Dominican Republic
Turkey
San Marino
Thailand
Nigeria
Uzbekistan
Taiwan
Iraq
Azerbaijan
Bahamas
Iceland
Namibia
Sweden
United Arab Emirates
Jamaica
Tanzania
Honduras
Slovenia
Bolivia
Isle of Man
Luxembourg
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Albania
Pakistan
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Grenada
Jordan
Bangladesh
Russian Federation
Argentina
Romania
Kenya
Kazakhstan
Cayman Islands
Cambodia
Latvia
Cyprus
Oman
Cameroon
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Seychelles
Investors in Taiwan by industry
Financial Services
Cryptocurrency
Payments
Restaurants
Food and Beverage
Fashion
Medical Device
Transportation
Medical
Internet
Social Media
Mobile
Software
Automotive
Travel
Biotechnology
Enterprise
Consumer
Health Care
Sustainability
Energy
Climate
Impact
SaaS
Marketplace
Hardware
Artificial intelligence
Gaming
Retail
Education
Blockchain
Big Data
Biotech
EdTech
Community
Mobile Apps
Wellness
Manufacturing
Web3
Agriculture (agtech)
Media (entertainment)
Machine Learning
B2B
FinTech